RGD Reference Report - Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer. - Rat Genome Database

Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

Common variants in immune and DNA repair genes and risk for human papillomavirus persistence and progression to cervical cancer.

Authors: Wang, SS  Bratti, MC  Rodriguez, AC  Herrero, R  Burk, RD  Porras, C  Gonzalez, P  Sherman, ME  Wacholder, S  Lan, ZE  Schiffman, M  Chanock, SJ  Hildesheim, A 
Citation: Wang SS, etal., J Infect Dis. 2009 Jan 1;199(1):20-30. doi: 10.1086/595563.
RGD ID: 11344886
Pubmed: PMID:19012493   (View Abstract at PubMed)
PMCID: PMC3690375   (View Article at PubMed Central)
DOI: DOI:10.1086/595563   (Journal Full-text)

BACKGROUND: We examined host genetic factors to identify those more common in individuals whose human papillomavirus (HPV) infections were most likely to persist and progress to cervical intraepithelial neoplasia grade 3 (CIN3) and cancer. METHODS: We genotyped 92 single-nucleotide polymorphisms (SNPs) from 49 candidate immune response and DNA repair genes obtained from 469 women with CIN3 or cancer, 390 women with persistent HPV infections (median duration, 25 months), and 452 random control subjects from the 10,049-woman Guanacaste Costa Rica Natural History Study. We calculated odds ratios and 95% confidence intervals (CIs) for the association of SNP and haplotypes in women with CIN3 or cancer and HPV persistence, compared with random control subjects. RESULTS: A SNP in the Fanconi anemia complementation group A gene (FANCA) (G501S) was associated with increased risk of CIN3 or cancer. The AG and GG genotypes had a 1.3-fold (95% CI, 0.95-1.8-fold) and 1.7-fold (95% CI, 1.1-2.6-fold) increased risk for CIN3 or cancer, respectively (P(trend) = .008; referent, AA). The FANCA haplotype that included G501S also conferred increased risk of CIN3 or cancer, as did a different haplotype that included 2 other FANCA SNPs (G809A and T266A). A SNP in the innate immune gene IRF3 (S427T) was associated with increased risk for HPV persistence (P(trend) = .009). CONCLUSIONS: Our results require replication but support the role of FANCA variants in cervical cancer susceptibility and of IRF3 in HPV persistence.

RGD Manual Disease Annotations    Click to see Annotation Detail View
TermQualifierEvidenceWithReferenceNotesSourceOriginal Reference(s)
cervical cancer  IAGP 11344886DNA:SNPs more ...RGD 
cervical cancer  ISOFANCA (Homo sapiens)11344886; 11344886DNA:SNPs more ...RGD 

Objects Annotated

Genes (Rattus norvegicus)
Fanca  (FA complementation group A)

Genes (Mus musculus)
Fanca  (Fanconi anemia, complementation group A)

Genes (Homo sapiens)
FANCA  (FA complementation group A)


Additional Information